156 related articles for article (PubMed ID: 2612546)
1. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.
Trenk D; Wagner F; Sachs W; Jähnchen E
Eur J Clin Pharmacol; 1989; 37(3):313-6. PubMed ID: 2612546
[TBL] [Abstract][Full Text] [Related]
2. Influence of food on the bioavailability and some pharmacokinetic parameters of diprafenone--a novel antiarrhythmic agent.
Koytchev R; Alken RG; Mayer O; Smith I; Greenwood M
Eur J Clin Pharmacol; 1996; 50(4):315-9. PubMed ID: 8803526
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and metabolism of the antiarrhythmic agent [3H]-diprafenone in the rat.
Brunner F; Kolmayr U; Kukovetz WR
Arzneimittelforschung; 1989 Nov; 39(11):1430-5. PubMed ID: 2619776
[TBL] [Abstract][Full Text] [Related]
4. Enantioselective determination of diprafenone in human plasma.
Zhong D; Chen R; Fieger-Büschges H; Blume H
Pharmazie; 1997 Feb; 52(2):106-9. PubMed ID: 9122271
[TBL] [Abstract][Full Text] [Related]
5. [HPLC determination of diprafenone and its active metabolite 5-hydroxydiprafenone in human plasma].
Zhong D; Blume H
Pharmazie; 1994 Jan; 49(1):38-41. PubMed ID: 8140128
[TBL] [Abstract][Full Text] [Related]
6. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man.
Wagner F; Jähnchen E; Trenk D
Eur J Clin Pharmacol; 1989; 36(6):579-82. PubMed ID: 2570700
[TBL] [Abstract][Full Text] [Related]
8. Diprafenone for treatment of Wolff-Parkinson-White syndrome.
Kunze KP; Schlüter M; Geiger M; Kuck KH
Cardiovasc Drugs Ther; 1989 Mar; 3(1):73-9. PubMed ID: 2487525
[TBL] [Abstract][Full Text] [Related]
9. Effect of diprafenone on the pharmacokinetics of digoxin.
Koytchev R; Alken RG; Mayer O
Eur J Clin Pharmacol; 1996; 50(1-2):97-100. PubMed ID: 8739818
[TBL] [Abstract][Full Text] [Related]
10. [Electrophysiologic and hemodynamic effects of the new anti-arrhythmia agent diprafenone].
Gülker H; Heuer H; Thale J; Behrenbeck T
Z Kardiol; 1987 Jul; 76(7):411-4. PubMed ID: 3673162
[TBL] [Abstract][Full Text] [Related]
11. Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteers.
Hinderling PH; Tendolkar A; Dee CM; Barr WH; Seiberling M; Duerr H
J Clin Pharmacol; 1995 Jul; 35(7):721-9. PubMed ID: 7560253
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol.
Greenberg S; Cantor E; Paul J
J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625
[TBL] [Abstract][Full Text] [Related]
13. Comparative bioavailability of propafenone after administration of a magistral suspension vs. commercial tablets in healthy volunteers.
Juárez Olguín H; Flores Pérez C; Ramírez Mendiola B; Barranco Garduño L; Sandoval Ramírez E; Flores Pérez J
Arzneimittelforschung; 2009; 59(3):117-20. PubMed ID: 19402341
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of an extemporaneous suspension of propafenone made from tablets.
Olguín HJ; Pérez CF; Pérez JF; Mendiola BR; Portugal MC; Chávez JB
Biopharm Drug Dispos; 2006 Jul; 27(5):241-5. PubMed ID: 16586461
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the beta-adrenoceptor blocking property of diprafenone in rats: stereoselective interaction, subtype specificity, and sensitization.
Nanoff C; Schütz W
J Cardiovasc Pharmacol; 1991 Dec; 18(6):837-42. PubMed ID: 1725895
[TBL] [Abstract][Full Text] [Related]
16. Influence of the new class I antiarrhythmic agent diprafenone on the end-systolic pressure-volume relationship (conductance technique).
Thormann J; Kramer W; Kremer P; Schlepper M
Cardiovasc Drugs Ther; 1989 Apr; 3(2):145-54. PubMed ID: 2487530
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
Klotz U; Müller-Seydlitz P; Heimburg P
Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462
[TBL] [Abstract][Full Text] [Related]
18. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
Groschner K; Lindner W; Schnedl H; Kukovetz WR
Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
[TBL] [Abstract][Full Text] [Related]
19. Diprafenone.
Drugs R D; 1999 Apr; 1(4):301-3. PubMed ID: 10566049
[No Abstract] [Full Text] [Related]
20. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
